eClinical Provider DATATRAK joins SAS® Alliance to Offer Cloud-Based SAS® Drug Development

eClinical Provider DATATRAK joins SAS® Alliance to Offer Cloud-Based SAS® Drug

PR Newswire

CLEVELAND, June 19, 2013

CLEVELAND, June 19, 2013 /PRNewswire/ --DATATRAK International, Inc. (OTCQX:
DTRK), a leader in developing cloud-based, unified eClinical® technologies and
delivering related services for the clinical trials industry, today announced
their partnership with SAS to provide SAS® Drug Development as an extension of
the DATATRAK ONE™ solution.


"As the innovator in cloud-based eClinical solutions, DATATRAK brings the
power of SAS Drug Development to customers with our rapid integration
capabilities," stated Laurence P. Birch, DATATRAK's Chairman of the Board and
CEO. "DATATRAK customers already enjoy real-time access to all of their study
data with our unified platform. Adding SAS Drug Development to our arsenal
gives users the power of SAS Analytics across all their unified data,
accelerating the drug development process through greater data visibility and
real-time analysis."

Aimed at transforming clinical research processes through repeatable,
sustainable improvements, DATATRAK will work with SAS to make SAS Drug
Development available in the cloud, providing data flow from DATATRAK ONE™
into SAS Drug Development. The seamless integration is designed to streamline
work processes for a company-wide implementation across the breadth of a drug
development program. Intended to support Clinical Data Interchange Standards
Consortium (CDISC) standards, the integrated cloud-based solution will be
designed to leverage DATATRAK's unified platform with workflows, document
management, and analysis to support the current needs and future business
growth of life sciences organizations.

SAS Drug Development helps organizations make informed clinical and business
decisions; streamline and optimize analysis and reporting processes; assess
safety and efficacy more effectively; and improve collaboration with business
partners and regulatory authorities. It eases analysis and reporting for
single trials as well as aggregated clinical data assets across multiple
trials or therapies.

Join DATATRAK Thought Leaders:

  oThe DATATRAK Blog

Tweet: DATATRAK provides SAS® Drug Development in the cloud 

DATATRAK International is a worldwide technology and services company
delivering unified eClinical® solutions and related services for the clinical
trials industry. DATATRAK built its multi-component, comprehensive solution on
a single, unified platform and expanded this concept to include services
delivery via DATATRAK's Clinical and Consulting Services group. The Company
delivers a complete portfolio of software products designed to accelerate the
reporting of clinical research data from sites to sponsors and ultimately
regulatory authorities, faster and more efficiently than loosely integrated
technologies. The DATATRAK ONE™ software solution, deployed worldwide through
an ASP or Enterprise Transfer offering, supports Phase I – Phase IV drug and
device studies in multiple languages throughout the world. DATATRAK has
offices located in Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North
Carolina. For more information, visit 

Except for the historical information contained in this press release, the
statements made in this release are forward-looking statements. These
forward-looking statements are made based on management's expectations,
assumptions, estimates and current beliefs concerning the operations, future
results and prospects of the Company and are subject to uncertainties and
factors which are difficult to predict and, in many instances, are beyond the
control of the Company, and which could cause actual results to differ
materially from those contemplated in these forward-looking statements. For a
list of certain factors that may cause actual results to differ materially
from those contemplated in these forward looking statements, please see the
Company's report filed with the OTCQX Market on May 15, 2013 announcing its
results for the first quarter of 2013. The Company undertakes no obligation to
update publicly or revise any forward-looking statement whether as a result of
new information, future events or otherwise.

SOURCE DATATRAK International, Inc.

Contact: Lisa Pahl, Director Marketing, DATATRAK International, Inc.,
Press spacebar to pause and continue. Press esc to stop.